首页> 外国专利> The eradication of B cells is like enanti CD20 antibody or theta P alpha A, a alpha tau alpha as an annual treatment. These devices are obsessive-compulsive disorder.

The eradication of B cells is like enanti CD20 antibody or theta P alpha A, a alpha tau alpha as an annual treatment. These devices are obsessive-compulsive disorder.

机译:消灭B细胞就像是enanti CD20抗体或theta P alpha A(每年一次使用alpha tau alpha)。这些装置是强迫症。

摘要

The present invention relates to an anti-CD20 antibody or an anti-CD20 antibody eliminating this fragment of B-cell CD20 therapy in mooring in the first topic. Chronic fatigue and muon alphaEncephalomyelitis.Especially,The present invention relates to a monoclonal antibody against CD20 or its fragment which is preferred to be alpha___ Chronic fatigue syndrome / myalgiaA potential encephalomyelitis suffers from these diseases.
机译:本发明涉及在第一主题中的系泊中消除B细胞CD20治疗的该片段的抗CD20抗体或抗CD20抗体。慢性疲劳和μon型脑脊髓炎。特别地,本发明涉及抗CD20或其片段的单克隆抗体,其优选为α慢性慢性综合征/肌痛潜在的脑脊髓炎患有这些疾病。

著录项

  • 公开/公告号CY1118918T1

    专利类型

  • 公开/公告日2018-01-10

    原文格式PDF

  • 申请/专利权人 BERGEN TEKNOLOGIOVERFØRING AS;

    申请/专利号CY201711000535T

  • 发明设计人 MELLA OLAV;FLUGE ØYSTEIN;

    申请日2017-05-22

  • 分类号C07K16/28;A61K39/395;

  • 国家 CY

  • 入库时间 2022-08-21 12:53:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号